Search academic texts

Information × Registration Number 0206U004960, 0103U000295 , R & D reports Title Coagulologic, immunologic and clinical characteristics of lupus anticoagulant and determination of its role in development of resistance to substitution therapy for hemophilic patients. popup.stage_title Head Loginsky V.E., Registration Date 10-04-2006 Organization LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE popup.description2 Character, specificity, clinical consequences, features of resistance to substitution therapy, caused by occurrence of immune inhibitor and Antiphospholipid Antibodies (APLA) in hemophilic patients were studied. Criteria of laboratory diagnostics of LA in patients with primary disorder of internal mechanism of thrombinogenesis, caused by factor VIII activity deficit; as well as criteria of differentiation from neutralizing inhibitor were developed. Product Description popup.authors popup.nrat_date 2020-04-02 Close